M42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP)
Explore MoreM42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
Explore MoreLaunch groundbreaking effort to advance precision medicine by delivering pharmacogenomic insight at the point of care
Explore MoreM42 formalizes its 12-year presence in the Kingdom at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare
Explore MoreMore than 300 delegates from government, industry, academia, and civil society gathered in Abu Dhabi for the Water Quality Forum 2025, a high impact two-day event hosted by the Abu Dhabi Quality and Conformity Council (ADQCC) and M42’s Environmental Sciences.
Explore MoreThe groundbreaking, minimally invasive thoracic branch endoprosthesis, preserved brain and arm blood flow, sparing the patient from major open‑chest operation and enabling faster recovery
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology and genomics, is pioneering a more inclusive and empowering healthcare environment for People of Determination (POD) by becoming the first healthcare network in the region to join the Hidden Challenges Sunflower program and introducing portable hearing loop systems across its facilities.
Explore MoreHealthpoint, a leading surgical hospital and part of M42’s world-class portfolio, has partnered with Osstem Implant, the world’s third-largest dental implant manufacturer based in South Korea, to introduce cutting-edge Korean dental technology to its patients in Abu Dhabi.
Explore MoreCleveland Clinic Abu Dhabi introduces innovative Artisse Intrasaccular Flow Modulator for stroke treatment.
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology, and genomics, is pleased to announce the appointment of Dimitris Moulavasilis as the company’s new Group Chief Executive Officer, effective immediately. This change comes as Hasan Jasem Al Nowais transitions from his role to continue as a member of M42’s Board after a long and successful tenure leading M42 and, previously, Mubadala Health.
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministr...
The CME-accredited conference gathered global experts to explore the latest guidelines, data, and advances in obesity care under...
M42 and ACTVET Empowering Emirati women to lead the future of sustainable healthcare in the UAE
M42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while ...
The new locations bring comprehensive screening solutions closer to Abu Dhabi’s growing communities
Recognition follows Malaffi's achievement as first Health Information Exchange in the MENA region to implement comprehensive cli...
